Quevedo, Raquel do A. P. http://orcid.org/0009-0002-7188-4694
de Melo, Maria Edna
Cercato, Cintia
Fernandes, Ariana E.
Dantas, Anna Carolina B.
Santo, Marco Aurélio
Pajecki, Denis
Mancini, Marcio C.
Article History
Received: 12 December 2023
Revised: 7 June 2024
Accepted: 7 June 2024
First Online: 13 July 2024
Declarations
:
: All procedures performed in studies involving human participants were approved by the ethical standards of the institutional and/or national research committee and in accordance with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The research project has a Certificate of Presentation of Ethical Appreciation issued by the Research Ethics Committee of the HCFMUSP under number 17127119.0.0000.0068.
: Informed consent was obtained from all individual participants included in the study.
: Raquel do Amaral Prado Quevedo declares no conflict of interest. Maria Edna de Melo has received consulting fees and support for travel from Novo Nordisk and BracePharma. Cintia Cercato has served as an advisory board for Novo Nordisk and reports having received research grants from Eli-Lilly, Novo Nordisk, Merck, Boehringer Ingelheim, Eurofarma, Fractyl, BracePharma, and EMS. Ariana Ester Fernandes declares no conflict of interest. Anna Carolina Batista Dantas declares no conflict of interest. Marco Aurélio Santo declares no conflict of interest. Denis Pajecki declares no conflict of interest. Marcio C. Mancini has received consulting fees, honoraria, and support for meetings or travel from Merck, Lilly, Novo Nordisk, Takeda, EMS, Eurofarma, BracePharma, Science Valley, and Aché.